Exacte Labs* is an analytical center founded in 2011. A leader in clinical trials, bioequivalence studies, drug pharmacokinetics, and laboratory diagnostics (routine and rare diagnostic tests).
Clients of the company are the largest pharmaceutical manufacturers of Russia, as well as international pharmaceutical companies.
Exacta Labs Bioanalytical Laboratory has participated in more than 500 bioequivalence and pharmacokinetic studies. The largest stock of equipment in Russia, 18 mass-spectrometers, which allow detecting low molecular weight compounds in biological samples with high precision.
Exacte Labs conducts research in the field of finished dosage forms, substances and excipients.
The company also develops analysis methods for new drugs.
The company employs market experts, more than 70 employees, including 6 candidates of science.
More than 20 scientific publications of our employees in Russian and foreign trade journals.
More than 50 projects of the central laboratory in clinical trials protocols.
- GLP certification (GOST 33044-2014), ISO 9001:2015.
- Adherence to GCP, GCLP principles.
- The availability of medical license, SES conclusion, permission for COVID-19 diagnostics by PCR method
- Certification GOST ISO/IEC 17025-2019
- Single integrated QMS
- Preparedness for any customer audits, also in English
- Risk-oriented approach in process management, business continuity management in accordance with BC/DRP plan
Digital Lab: digitalization of all solutions for the customer.
A one-stop shop for the customer on all matters Comprehensive services at all stages up to drug registration.
We will find a solution for your problems!
*From the Latin exacte - precision.